Current nonsurgical treatments of IBD mainly include the administration of corticosteroids, 5-aminosalicylic acid (5-ASA) preparations, and immune-suppressive drugs such as azathioprine.

Asana Medical will initially target product development for the treatment of Ulcerative Colitis ("UC"), one of the two major forms of IBD. Asana will then pursue use of this technology to treat ...